GMDS-DT and colorectal carcinoma: By analyzing GMDS-AS1 expression levels and clinicopathological feature data in the 50 CRC tissues and in The Cancer Genome Atlas (TCGA) colon adenocarcinoma (COAD) dataset [24], we found that late-TNM-stage CRC patients showed notably higher GMDS-AS1 expression (Fig. 1C and Table S6).